Health Sciences

Bringing art to inner city teens

Renee Andrea Mills of the Hospital of the University of Pennsylvania has a passion for helping people and a passion for art, and for the past 25 years, she has combined both in community outreach, sharing the joy of creativity.

Penn Today Staff

Cancer cells send out ‘drones’ to battle the immune system from afar

Checkpoint inhibitor therapies have made metastatic melanoma and other cancers a survivable condition, but only for some patients. Researchers uncovered a novel mechanism by which tumors suppress the immune system, raising the possibility that a straightforward blood test could predict which patients could respond to immunotherapy.

Karen Kreeger

Ensuring equality with a framework for workforce inclusion

A study published in JAMA Network Open from researchers at the Perelman School of Medicine identifies six factors that measure workforce inequality in delivering health care, as part of Office of Inclusion and Diversity’s equality mission.

Penn Today Staff

Mentoring program introduces high school students to dentistry

The Summer Mentorship Program introduces first-generation and under-represented high school students in Philadelphia to higher education possibilities, including Penn Dental School's four-week immersion program that includes hands-on experience and mentorship with current dental students.

Penn Today Staff

Therapy for rare cancers receives FDA approval

A trial led by researchers at the Abramson Cancer Center received first approval for AZEDRA, an anti-cancer drug for advanced pheochromocytoma and paraganglioma patients who are not candidates for surgery.

Penn Today Staff

The fight to eliminate hepatitis C in Philly: A Q&A with Stacey Trooskin

The state of Pennsylvania increased access to hepatitis C drugs for Medicaid patients regardless of their liver health or drug and alcohol use. Penn's Stacey Trooskin, who also serves as the director of Viral Hepatitis Programs at Philadelphia FIGHT, discusses increasing access to treatment even further.

Penn Today Staff



In the News


Philadelphia Inquirer

New hepatitis C drugs mean diseased organs can be used for transplants

The Perelman School of Medicine’s Peter Reese discussed the possibility of increased rejection in patients who’ve received infected kidneys, saying “we can’t rule it out. It’s possible there’s more immunological injury with hep C infection.”

FULL STORY →



The New York Times

Clues to your health are hidden at 6.6 million spots in your DNA

Daniel Rader of the Perelman School of Medicine discussed the availability of genetic screening for early indicators of heart disease.

FULL STORY →



Associated Press

Penn Medicine eliminating sugary drinks in facilities

Ralph Muller of Penn Medicine discussed the hospital system’s recent announcement regarding the phasing out of sugary drink sales.

FULL STORY →



Philadelphia Inquirer

Cancer ‘drones’ in blood weaken immune system, Penn scientists show

Wei Guo of the School of Arts and Sciences and George Xu of the Perelman School of Medicine discussed their team’s cancer research. “Tumor cells are smarter than we thought,” said Guo.

FULL STORY →



Philadelphia Inquirer

Hyperbaric oxygen: The mysterious therapy that saved a cancer survivor from radiation side effects

Hyperbaric therapy is controversial, according to Matthew Kelly of HUP, largely because “it’s expensive, and some practitioners overuse it, which gives a black eye to the field.” However, for some patients, the oxygen-rich environment can promote healing and fight infection.

FULL STORY →